ClinicalTrials.Veeva

Menu

Effect of 0.1% Pilocarpine Mouthwash on Xerostomia

J

Jeong-seong Kwon

Status

Completed

Conditions

Xerostomia

Treatments

Drug: saline
Drug: Pilocarpine

Study type

Interventional

Funder types

Other

Identifiers

NCT01627626
2-2011-0032

Details and patient eligibility

About

The aim of this study is to evaluate the effect of 0.1% pilocarpine mouthwash on subjective dryness, minor salivary flow rates and unstimulated whole salivary flow rate in xerostomic patients.

Enrollment

60 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • xerostomia for 3 months or more, and
  • adults aged 20 years and older.

Exclusion criteria

  • acute asthma attack
  • acute iritis
  • narrow angle glaucoma
  • pilocarpine allergy
  • pregnancy
  • lactating women, and
  • person who was treating xerostomia with artificial saliva, pilocarpine, or etc.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

0.1% pilocarpine mouthwash
Experimental group
Description:
0.1% pilocarpine solution which diluted 2% pilocarpine hydrochloride eyedrop with 0.9% saline
Treatment:
Drug: Pilocarpine
0.9% saline mouthwash
Placebo Comparator group
Description:
0.9% saline as a mouthwash
Treatment:
Drug: saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems